pI: 5.7152 |
Length (AA): 248 |
MW (Da): 27373 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 245 | 5lil (A) | 1 | 237 | 41.00 | 0 | 1 | 1.5714 | -1.11 |
5 | 240 | 4u00 (A) | 3 | 232 | 43.00 | 0 | 1 | 1.55811 | -1.24 |
5 | 225 | 5lj9 (A) | 3 | 222 | 37.00 | 0 | 1 | 1.48513 | -1.33 |
6 | 230 | 2pcj (A) | 4 | 223 | 39.00 | 0 | 1 | 1.51576 | -1.46 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Dormant phase. | murphy |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Dormant phase. | hasan |
murphy | Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. |
hasan | Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis. |
Ortholog group members (OG5_126906)
Species | Accession | Gene Product |
---|---|---|
Chlamydia trachomatis | CT_152 | ABC transporter ATPase |
Dictyostelium discoideum | DDB_G0267428 | hypothetical protein |
Dictyostelium discoideum | DDB_G0292384 | hypothetical protein |
Escherichia coli | b0495 | putative ABC superfamily transporter ATP-binding subunit |
Escherichia coli | b0879 | fused macrolide transporter subunits of ABC superfamily: ATP-binding component/membrane component |
Escherichia coli | b1117 | outer membrane-specific lipoprotein transporter subunit |
Entamoeba histolytica | EHI_114390 | ABC transporter, putative |
Entamoeba histolytica | EHI_099870 | ATP-binding cassette, putative |
Leishmania braziliensis | LbrM.29.1750 | ABC transporter domain protein, putative |
Leishmania braziliensis | LbrM.19.0280 | ABC transporter |
Leishmania donovani | LdBPK_291780.1 | ATP-binding cassette protein subfamily H, member 2, putative |
Leishmania donovani | LdBPK_110040.1 | ATP-binding cassette protein subfamily H, member 1, putative |
Leishmania infantum | LinJ.29.1780 | ATP-binding cassette protein subfamily H, member 2, putative |
Leishmania infantum | LinJ.11.0040 | ATP-binding cassette protein subfamily H, member 1, putative |
Leishmania major | LmjF.11.0040 | ATP-binding cassette protein subfamily H, member 1, putative |
Leishmania major | LmjF.29.1640 | ATP-binding cassette protein subfamily H, member 2, putative |
Leishmania mexicana | LmxM.11.0040 | ABC transporter, putative |
Leishmania mexicana | LmxM.08_29.1640 | ABC transporter domain protein, putative |
Mycobacterium tuberculosis | Rv0986 | Probable adhesion component transport ATP-binding protein ABC transporter |
Mycobacterium tuberculosis | Rv2564 | Probable glutamine-transport ATP-binding protein ABC transporter GlnQ |
Mycobacterium tuberculosis | Rv0073 | Probable glutamine-transport ATP-binding protein ABC transporter |
Mycobacterium ulcerans | MUL_0674 | ABC transporter ATP-binding protein |
Neospora caninum | NCLIV_058820 | ABC transporter, putative |
Schmidtea mediterranea | mk4.028825.00 | |
Trypanosoma cruzi | TcCLB.509669.30 | ABC transporter, putative |
Trypanosoma cruzi | TcCLB.510381.20 | ABC transporter, putative |
Trypanosoma cruzi | TcCLB.506905.40 | ABC transporter, putative |
Trypanosoma cruzi | TcCLB.509617.80 | ABC transporter, putative |
Treponema pallidum | TP0581 | ABC transporter, ATP-binding protein |
Treponema pallidum | TP0964 | ABC transporter, ATP-binding protein |
Wolbachia endosymbiont of Brugia malayi | Wbm0023 | peptide ABC transporter ATPase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu2608 | Mycobacterium tuberculosis | non-essential | nmpdr |
b0495 | Escherichia coli | non-essential | goodall |
b0879 | Escherichia coli | non-essential | goodall |
b1117 | Escherichia coli | essential | goodall |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.5